Inhibikase Therapeutics Inc (NAS:IKT)
$ 3.05 -0.01 (-0.33%) Market Cap: 205.61 Mil Enterprise Value: 195.79 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 37/100